EOFLOW Receives Breakthro...
국내 웨어러블 의료기기 벤처 회사인 이오플로우㈜(대표 김재진, 이하 ‘이오플로우’)가 개발 중인 일체형 웨어러블 인공췌장 시스템(영문 제품명 EOPancreas, 이하 국내 제품명, ‘이오파니’)이 최근 미국 식품의약국(이하 ‘FDA’)으로부터 ‘획기적인 의료기기 프로그램(Breakthrough Devices Program)’에 선정되었다. 이 프로그램은 일종의 신속심사를 위한 제도로서, 현존하지 않는 신의료기기 중 시장의 요구가 ...
Mar.14.2019
EOFLOW Receives Breakthro...
EOFlow Receives FDA Breakthrough Device Designation on its Integrated Wearable Automated Insulin Delivery System SAN JOSE, USA and SEOUL, South Korea, March 14, 2019 EOFLOW CO., Ltd., an emerging medical device company with offices in Seoul, South Korea and San Jose, California, announc...
Mar.14.2019
제3자 배정방식 신주발행 공고 (in Kore...
이오플로우㈜ 주주님께 제3자 배정 방식의 신주발행 공고 당 회사는 2019년 02월 25일 이사회 결의로 아래와 같이 제3자 배정 유상증자를 시행하기로 결의하였음을 공고합니다.. - 아 래 – 1. 발행주식의 종류와 수: 기명식 보통주 칠십이만주(720,000주) 2. 신주의 발행가액: 주당 일만삼천팔백육십원정(\13,860) 3. 신주의 발행총액: 구십구억칠천구백이십만원정(\9,979,200,00...
Mar.04.2019
Call for shareholders' me...
주주님의 번영과 안녕을 기원합니다 당사는 상법 제363조와 정관 제22조에 의거하여 제8기 정기주주총회를 아래와 같이 소집하오니 주주님께서는 참석하여 주시기 바랍니다. - 아 래 – 1. 일 시: 2019년 03월 29일(금요일) 오전 09시 2. 장 소: 경기도 성남시 분당구 돌마로 172 분당서울대병원 헬스케어혁신파크 1층 2세미나실 3. 회의목적사항 가. 보고사항: 감사보고...
Mar.04.2019
EOFLOW presents at Diabet...
Dr. Ian Welsford, the Chief Compliance Officer at EOFLOW, spoke at the 2018 Diabetes Technology Meeting held in Bethesda, MD on November 8th. At the event, Dr. Welsford presented 'A Novel Patch Pump' where he discussed the possibilities of a smart wearable insulin patch ...
Nov.15.2018
EOFLOW awarded at Start-U...
EOFLOW was one of the top two award winners at the SF2018 (Start-up Festival 2018), a highly recognized event for startups, held by KISED (Korean Institute of Startups and Entrepreneurship Development) and sponsored by the Ministry of SMEs and Startups. EOFLOW is being recognized as one of the...
Nov.09.2018
EOFLOW and K-Bio Health s...
K-Bio Health and EOFLOW sign an MOU to cooperate in developing and commercializing wearable automated insulin delivery solutions. K-Bio Health is one of the largest healthcare-focused development & testing labs supported by the Korean Ministry of Health. You can read more about the news at one o...
Oct.01.2018
EOFLOW's product chosen a...
EOFLOW was recently informed that SPINOFF.COM had chosen EOFLOW's 'tiny wearable artificial pancreas' as one of 'the Top 100 Science Spinoffs.' The product has 'entered 2 % out of 5,000 global science spinoffs according to the following criteria: uniqueness of the techn...
Aug.16.2018
EOFLOW mentioned as a maj...
EOFLOW was mentioned as one of four medical device companies in Korea developing world-class product by Hankyung, a major economic newspaper in Korea. Read the article with this link (in Korean only): http://news.hankyung.com/health/article?aid=2018080661121
Aug.09.2018
EOFLOW will be at the 201...
EOFLOW will exhibit at the 2018 54th EASD (European Association for the Study of Diabetes) held in Berlin, Germany, 10/02 - 10/04/2018. EOFLOW's booth is 3.Q02. Please contact us in advance if you'd like to arrange a meeting wi...
Aug.06.2018
